The whole world of gambling is on your smartphone with the Mostbet app - join us!
Home  »  Companies   »  An In-Depth Look at Asensus Surgical Inc.’s ...

An In-Depth Look at Asensus Surgical Inc.’s (ASXC) Stock Performance

In the past week, ASXC stock has gone down by -9.38%, with a monthly decline of -2.49% and a quarterly plunge of -47.27%. The volatility ratio for the week is 10.50%, and the volatility levels for the last 30 days are 10.17% for Asensus Surgical Inc. The simple moving average for the past 20 days is -2.61% for ASXC’s stock, with a -46.16% simple moving average for the past 200 days.

Is It Worth Investing in Asensus Surgical Inc. (AMEX: ASXC) Right Now?

The 36-month beta value for ASXC is also noteworthy at 1.62. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


The average price estimated by analysts for ASXC is $1.50, which is $1.21 above than the current price. The public float for ASXC is 259.20M, and at present, short sellers hold a 4.23% of that float. The average trading volume of ASXC on September 18, 2023 was 2.72M shares.

ASXC) stock’s latest price update

Asensus Surgical Inc. (AMEX: ASXC) has experienced a decline in its stock price by -9.91 compared to its previous closing price of 0.32. However, the company has seen a fall of -9.38% in its stock price over the last five trading days. PennyStocks reported 2023-09-13 that Let’s be honest – penny stocks priced at less than a buck hold an irresistible appeal. Even a small investment could potentially lead to insane returns.

Analysts’ Opinion of ASXC

Many brokerage firms have already submitted their reports for ASXC stocks, with Cantor Fitzgerald repeating the rating for ASXC by listing it as a “Overweight.” The predicted price for ASXC in the upcoming period, according to Cantor Fitzgerald is $1.50 based on the research report published on September 08, 2022 of the previous year 2022.

ASXC Trading at -23.27% from the 50-Day Moving Average

After a stumble in the market that brought ASXC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -75.42% of loss for the given period.

Volatility was left at 10.17%, however, over the last 30 days, the volatility rate increased by 10.50%, as shares surge +3.20% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -38.95% lower at present.

During the last 5 trading sessions, ASXC fell by -9.38%, which changed the moving average for the period of 200-days by -29.27% in comparison to the 20-day moving average, which settled at $0.2982. In addition, Asensus Surgical Inc. saw -16.45% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at ASXC starting from Biffi Andrea, who purchase 293,077 shares at the price of $0.71 back on Mar 03. After this action, Biffi Andrea now owns 492,815 shares of Asensus Surgical Inc., valued at $207,557 using the latest closing price.

Stock Fundamentals for ASXC

Current profitability levels for the company are sitting at:

  • -1063.40 for the present operating margin
  • -162.17 for the gross margin

The net margin for Asensus Surgical Inc. stands at -1066.19. The total capital return value is set at -53.81, while invested capital returns managed to touch -54.24. Equity return is now at value -90.10, with -76.00 for asset returns.

Based on Asensus Surgical Inc. (ASXC), the company’s capital structure generated 5.56 points at debt to equity in total, while total debt to capital is 5.27. Total debt to assets is 4.72, with long-term debt to equity ratio resting at 4.75. Finally, the long-term debt to capital ratio is 4.50.

When we switch over and look at the enterprise to sales, we see a ratio of 1.63, with the company’s debt to enterprise value settled at 0.32. The receivables turnover for the company is 4.72 and the total asset turnover is 0.05. The liquidity ratio also appears to be rather interesting for investors as it stands at 8.34.


In summary, Asensus Surgical Inc. (ASXC) has had a bad performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Should You Invest in BP p.l.c. (BP) Now?

BP p.l.c. (NYSE: BP) has a higher price-to-earnings ratio of 5.78x compared to its average ratio, and the 36-month beta value for BP is at